Literature DB >> 19211580

High incidence of factor V Leiden and prothrombin G20210A in healthy southern Italians.

Gianluca Sottilotta1, Corrado Mammì, Giuseppe Furlò, Vincenzo Oriana, Caterina Latella, Vincenzo Trapani Lombardo.   

Abstract

Factor V Leiden (FVL) and G20210 prothrombin (FII G20210A) mutations are risk factors for thromboembolism. In Europe, FVL is more prevalent in the north (7%) than in the south (3%), whereas FII G20210A is more common in the south (3% to 7%) than in the north (2% to 5%). In Italy, the prevalence is 2% to 3% for both. The aim of this study was to assess if these polymorphisms could be more frequent in the south than in the rest of Italy. In 105 blood donors in southern Italy, the prevalence of FVL and FIIG20210A was 9.5% and 5.7%, respectively. These prevalence data are higher when compared with published data. The results of this study are as high as those observed in Greece and the Middle East. The diffusion of FVL and FII G20210A in the Mediterranean, consequent to Phoenician and Greek colonization, could be a reason for the high prevalence observed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19211580     DOI: 10.1177/1076029607310218

Source DB:  PubMed          Journal:  Clin Appl Thromb Hemost        ISSN: 1076-0296            Impact factor:   2.389


  8 in total

Review 1.  Humans, mice, and mechanisms of intestinal atresias: a window into understanding early intestinal development.

Authors:  Peter F Nichol; Amy Reeder; Robert Botham
Journal:  J Gastrointest Surg       Date:  2010-11-30       Impact factor: 3.452

2.  Large-scale screening for factor V Leiden (G1691A), prothrombin (G20210A), and MTHFR (C677T) mutations in Greek population.

Authors:  Alkistis Raptopoulou; Vassiliki Michou; Niki Mourtzi; Efstathia G Papageorgiou; Chrysa Voyiatzaki; Vassilis Tsilivakos; Apostolos Beloukas; Thaleia A Bei
Journal:  Health Sci Rep       Date:  2022-07-15

3.  Epidemiology of Prothrombin G20210A Mutation in the Mediterranean Region.

Authors:  Mehrez M Jadaon
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-11-28       Impact factor: 2.576

4.  Epidemiology of activated protein C resistance and factor v leiden mutation in the mediterranean region.

Authors:  Mehrez M Jadaon
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-09-08       Impact factor: 2.576

5.  Evaluation of a high throughput method for the detection of mutations associated with thrombosis and hereditary hemochromatosis in Brazilian blood donors.

Authors:  Vivian Dionisio Tavares Niewiadonski; Juliana Vieira Dos Santos Bianchi; Cesar de Almeida-Neto; Nelson Gaburo; Ester Cerdeira Sabino
Journal:  PLoS One       Date:  2015-05-08       Impact factor: 3.240

6.  Allele frequency distribution of 1691G >A F5 (which confers Factor V Leiden) across Europe, including Slavic populations.

Authors:  Jeremy S C Clark; Grażyna Adler; Nermin N Salkic; Andrzej Ciechanowicz
Journal:  J Appl Genet       Date:  2013-11       Impact factor: 3.240

7.  The prevalence of Factor V Leiden (Arg506Gln) mutation in King Khalid University Hospital patients, 2017-2019.

Authors:  Maram Al-Otaiby; Rahaf Althnayan; Alanoud Binmethem; Reema Bader AlEnezy; Munira Abdulrahman Alhadlg; Arjuwana Alaqeel; Sara H AlQahtani; Noman Ghufran; Abdulaziz A Alotaibi; Nada Alayed; Imran Ali Khan
Journal:  Nagoya J Med Sci       Date:  2021-08       Impact factor: 1.131

8.  Prevalence of thrombophilia-associated genetic risk factors in blood donors of a regional hospital in southern Brazil.

Authors:  Jéssica Dick-Guareschi; Juliana Cristine Fontana; Maria Teresa Vieira Sanseverino; Francyne Kubaski; Leo Sekine; Nanci Félix Mesquita; Tor Gunnar Hugo Onsten; Sandra Leistner-Segal
Journal:  Hematol Transfus Cell Ther       Date:  2021-03-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.